|Articles|December 1, 2012
- Pharmaceutical Executive-12-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - December 2012
The Puzzle Master
Advertisement
Articles in this issue
about 13 years ago
Obamacare, Innovation and Pricingabout 13 years ago
Germany's Price Reform Revolutionabout 13 years ago
Transforming Drug Development: A Lilly–Covance Case Studyabout 13 years ago
The Puzzle Master: EMA's Guido Rasiabout 13 years ago
Top Medical Innovations for 2013Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
5
